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Client protein recruitment to the Hsp90 system
depends on cochaperones that bind the client and
Hsp90 simultaneously and facilitate their interaction.
Hsp90 involvement in the assembly of snoRNPs, RNA
polymerases, PI3-kinase-like kinases, and chromatin
remodeling complexes depends on the TTT (Tel2-
Tti1-Tti2), and R2TP complexes—consisting of the
AAA-ATPases Rvb1 and Rvb2, Tah1 (Spagh/RPAP3
in metazoa), and Pih1 (Pih1D1 in humans)—that
together provide the connection to Hsp90. The
biochemistry underlying R2TP function is still poorly
understood.Pih1 inparticular, at theheart of thecom-
plex, has not been described at a structural level, nor
have the multiple protein-protein interactions it
mediates been characterized. Here we present a
structural and biochemical analysis of Hsp90-Tah1-
Pih1, Hsp90-Spagh, and Pih1D1-Tel2 complexes
that reveal a domain in Pih1D1 specific for binding
CK2 phosphorylation sites, and together define the
structural basis bywhich theR2TPcomplexconnects
the Hsp90 chaperone system to the TTT complex.
INTRODUCTION
The R2TP complex is implicated in the stabilization and assem-
bly of an eclectic set of proteins andmacromolecular complexes
(Te et al., 2007; Zhao et al., 2005). These include RNA polymer-
ase 2 (Boulon et al., 2010), small nucleolar ribonucleoproteins
(snoRNPs; Kakihara and Houry, 2012), and phosphatidylinosi-
tol-3-kinase-like kinases (PIKKs) such asmTOR and SMG1 (Hor-
ejsı´ et al., 2010; Takai et al., 2010). The R2TP complex is found in
organisms from yeast to humans, and consists of the AAA+
ATPases Rvb1 and Rvb2 (human: RUVBL1 and RUVBL2), a
TPR-containing protein, Tah1 (human: Spagh or RPAP3), and
Pih1 (also known as NOP17 and Pih1D1, but referred to as
Pih1 henceforth; Kakihara and Houry, 2012; Te et al., 2007).
Pih1 is the multipoint scaffold of the R2TP complex, coupling
the Rvb1-Rvb2 hetero-dodecamer, the Hsp90 chaperone
machinery (via Tah1 in yeast or Spagh/RPAP3 in metazoa), andthe TTT (Tel2-Tti1-Tti2) complex implicated in activation and sta-
bilization of PIKKs (Hurov et al., 2010; Kakihara and Houry,
2012). Pih1 interaction with Rvb1-Rvb2 appears to be constitu-
tive and direct and requires a central region of Pih1 (Paci et al.,
2012), whereas the interaction of Pih1 with TTT is mediated by
a casein kinase 2 (CK2) phosphorylated motif in Tel2 and an
N-terminal region of Pih1 (Horejsı´ et al., 2010).
The biological roles ascribed to the R2TP complex are directly
associated with its ability to interact with the Hsp90 chaperone
system and function as an Hsp90 cochaperone (Boulon et al.,
2010; Izumi et al., 2012; Takai et al., 2010). In yeast, recruitment
of R2TP to Hsp90 is mediated by Tah1, a TPR-domain protein
that simultaneously binds the conserved C-terminal MEEVD
motif of Hsp90 and a C-terminal region of Pih1 (Eckert et al.,
2010). In metazoa, the interaction of Pih1 and Hsp90 is mediated
by Spagh/RPAP3, a much larger protein containing tandem TPR
domains as well as additional domains of unknown function.
Whereas the R2TP complex is implicated in a growing number
of biological processes, the mechanistic biochemistry underly-
ing its function is poorly understood (Kakihara and Houry,
2012). Pih1, the core scaffold protein of the complex, has not
been characterized structurally, nor have the protein-protein in-
teractions it mediates been described at a structural level. Here
we present crystal structures of Hsp90-Tah1-Pih1, Hsp90-
Spagh/RPAP3, and Pih1-Tel2 complexes that together define
key structural links within the R2TP core in yeast and in animals
(Figure 1) and reveal how R2TP connects the Hsp90 chaperone
system to the TTT complex involved in PIKK activation.
RESULTS
Structure of the Tah1-Pih1 Complex
We determined the crystal structure of full-length yeast Tah1,
bound to both the C-terminal segment of yeast Pih1264–344 and
the C-terminal tail peptide (SRMEEVD) of Hsp90 (Figure 2A),
by single-wavelength anomalous dispersion phasing of crystals
grown with selenomethionine-labeled Tah1 (see Experimental
Procedures) and refined to 2.2 A˚ (Table 1).
Consistent with earlier nuclear magnetic resonance studies
(Back et al., 2013; Jime´nez et al., 2012), the core of Tah1 is a
TPR domain, which consists of a helices arranged in a repeating
antiparallel right-handed helix topology. Unusually, Tah1-TPR
contains five helices rather than the seven found in otherStructure 22, 805–818, June 10, 2014 ª2014 The Authors 805
Figure 1. Hsp90-R2TP-Tel2 Connections
(A) Schematic of the chain of molecular in-
teractions that connect the Hsp90 chaperone
system to the Tel2 component of the TTT complex
in yeast. Dotted lines represent interactions
structurally defined in this study. N, M, and C
represent N-, middle, and C-domains, respec-
tively. TPR, tetratricopeptide repeat domain; CS,
CHORD domain-containing protein and Sgt1
domain; and PIH, protein interacting with Hsp90
domain.
(B) As in (A), but for the metazoan R2TP system in
which the role of Tah1 in yeast is fulfilled by Spagh/
RPAP3. Dotted lines represent interactions struc-
turally defined in this study.
Structure
Structure of R2TP Core Interactionsstructurally characterized Hsp90-binding TPR domains (Morgan
et al., 2012; Scheufler et al., 2000; Zhang et al., 2005). The C-ter-
minal 20 residues of Tah1 beyond the end of the fifth a helix of the
TPR domain has no coherent structure in the isolated protein in
solution (Back et al., 2013; Jime´nez et al., 2012), but is fully
ordered in the complex crystal structure, and forms the majority
of the interaction with Pih1 (see below). TheC-terminal domain of
Pih1264–344 consists of a seven-stranded b sandwich with the
topology of a CS domain—a structural motif also found in
Hsp90 cochaperones such as p23/Sba1 (Ali et al., 2006) and
Sgt1 (Zhang et al., 2008).
Tah1-Pih1 Interaction
The Tah1-Pih1-CS interaction buries 2,036 A˚2 of molecular
surface, which is in the range typically associated with constitu-
tive interactions (Krissinel and Henrick, 2007). Most (1,720 A˚2)
of this surface is buried by the C-terminal segment of Tah1 (Fig-
ure 2B). This segment snakes across one side of the Pih1-CS
domain, extending the three-stranded b sheet via main-chain in-
teractions between Ser 93 and Val 94 of Tah1 and Pro 299, Ser
300, Tyr 301, and Phe 303 of Pih1, before crossing over to
extend the four-stranded b sheet via interactions between Val
99 and Val 101 of Tah1, and Ile 331, Phe 332, and His 333 of
Pih1 (Figures 2B and 2C). These main-chain interactions are
bolstered by packing of the side chains of Tah1 residues Val
94, Ile 96, Val 98, and Val 101 into a shallow hydrophobic
channel formed by the side chains of Pih1 residues 297–303
and 326–334 on the edges of the stacked b sheets, with a806 Structure 22, 805–818, June 10, 2014 ª2014 The Authorssingle polar side chain interaction be-
tween Tah1-Glu 100 and Pih1-His 333
(Figure 2C).
Beyond the end of the b strand interac-
tion at Val 101, Tah1 makes a right-angle
bend at Asp 102 andGlu 103, packing the
side chains of Leu 104 and Tyr 108 into a
hydrophobic recess on the face of the
four-stranded b sheet of Pih1, formed
by the side chains of Ile 334, Phe 332,
Tyr 341, and Tyr 343 (Figure 2D). A further
bend in the trajectory of Tah1 forms
a network of intramolecular polar and
water-bridged interactions centered on
Tah1-Arg 110 and delivers the carboxylside chain of Asp 109 and the side chain and C-terminal
a-carboxyl of Ser 111 into a polar/ion pair interaction with the
basic side chains of Lys 272 and Arg 282 of Pih1 (Figure 2D).
The globular regions of the two proteins interact directly via a
hydrophobic interface involving the packing of Pih1-Phe 303 into
a pocket formed by Tah1 residues Thr 55, Ile 58, Val 91, Gly 92,
and Val 94. This is reinforced by a bidentate hydrogen bonding
interaction between the side chains of Tah1-Arg 66 and Pih1-
Asp 328, and a well-ordered water network (Figure 2E). Whereas
the extended C terminus of Tah1 dominates the interface with
Pih1, these additional interactions fix the relative position of
the two domains into a single globular entity.
Tah1 Interaction with the Conserved Hsp90-MEEVD
Motif
The Tah1-Pih1-CS heterodimer was cocrystallized with a pep-
tide incorporating the conserved C-terminal MEEVD motif found
at the C terminus of all eukaryotic cytoplasmic Hsp90s and is
essential for Hsp90 interaction with TPR-domain cochaperones.
In the Tah1-Pih1-CS complex, the Hsp90 ‘‘tail’’ peptide binds in
an extended groove lined by the helices forming the TPR
domain, and interacts with residues from the first, third, and fifth
helices. The conformation of the peptide and its interactions are
very similar to those observed for Hsp90 tail peptides bound to
the TPR domains of CHIP and AIP (Morgan et al., 2012; Zhang
et al., 2005) and essentially identical to those observed in a
recent nuclear magnetic resonance analysis of a Tah1-Hsp90
peptide complex (Back et al., 2013) and will not be described
Figure 2. Structure of Tah1- Pih1 Complex
(A) Secondary structure cartoon of TPR domain of
Tah1 (gold) bound to the CS domain of Pih1 (cyan)
and a peptide derived from the C terminus of
Hsp90 (sticks).
(B) Overview of the Tah1-Pih1 complex showing
the C-terminal segment of Tah1 (gold, carton
and sticks) extending across a shallow hydro-
phobic depression on the edge of Pih1-CS
domain (colored by electrostatic potential: +ve
blue/ ve red), and wrapping round to contact
the face of the four-stranded b sheet.
(C) The proximal part of the Tah1 C terminus
segment bridging the edges of the two b sheets of
the Pih1-CS domain b sandwich, with a combi-
nation of main chain to main chain hydrogen
bonds and hydrophobic interactions.
(D) Interaction of the distal part of the Tah1 C ter-
minus segment, forming amixed hydrophobic and
polar interface with the face of the four-stranded
b sheet.
(E) Outside the substantial interactionmediated by
the Tah1 C-terminal tail, the juxtaposition of the
Tah1-TPR and Pih1-CS domains is fixed by
an additional hydrophobic interaction, and an
extended polar interface anchored by a bidentate
hydrogen bond/ion-pair interaction.
(F) Interactions of the Tah1-TPR domain and
Hsp90 C-terminal peptide. The Hsp90 peptide
binds with compacted conformation stabilized by
interaction of the peptide backbone and side chain
of Glu 4, with the side chains of Tah1 residues Lys
50, Lys 79, and Arg 83. The a-carboxyl and
carboxylate side chain of Asp 7 is bound by a
‘‘carboxylate clamp’’ formed by Tah1 residues
Lys 8, Asn 12, Asn 43, and Lys 79. The side chain
of Met 3 in the Hsp90 peptide packs against
Tyr 82, but is far more exposed than those on other
Hsp90-TPR-domain complexes.
Structure
Structure of R2TP Core Interactionsin further detail. The major difference between the Tah1 complex
and the CHIP and AIP Hsp90-tail peptide complexes derives
from the lack of the two C-terminal a helices in the Tah1 TPR
structure. This leaves the methionine residue (M3 in Figure 2F)
in the peptide partially exposed, rather than buried in a pocket
at the interface of the fifth and seventh helices as in the com-
plexes with CHIP or AIP.
Stoichiometry of the Tah1-Hsp90 Interaction
In metazoa, the role of Tah1 is played by a larger protein, Spagh/
RPAP3, which has two tandem TPR domains as well as an
uncharacterized N terminus and a C-terminal Monad-bindingStructure 22, 805–8domain. We therefore used isothermal
titration calorimetry (ITC) to investigate
whether the stoichiometry for binding of
Tah1 and Spagh/RPAP3 to intact Hsp90
differed. Tah1 bound dimeric Hsp90
(KD = 5.9 mM) with a 1:1 stoichiometry
(one dimer Hsp90 and two monomers of
Tah1; Figure S1A available online). The
affinity (KD = 4 mM) and stoichiometry
were unaffected by the pre-assembledfull-length Tah1-Pih1 complex and dimeric Hsp90 (Figures S1A
and S1B). The similar affinity and stoichiometry in both cases
are consistent with formation of the (Hsp90)2-(Tah1)2 and
(Hsp90)2-(Tah1)2-(Pih1)2 complex. Furthermore, a mixture of
Tah1, Pih1, and the dimeric C-terminal domain of Hsp90 co-
eluted from a calibrated gel-filtration chromatography column
at a volume fully consistent with formation of a (Hsp90)2-
(Tah1)2-(Pih1)2 stoichiometric complex (Figure 3A).
We previously showed that some Hsp90 TPR-domain cocha-
perones occupy both of the C-terminal MEEVD motifs available
in an Hsp90 dimer, preventing the formation of mixed Hsp90-
TPR domain cochaperone complexes (Prodromou et al., 1999;18, June 10, 2014 ª2014 The Authors 807
Table 1. Crystallographic Statistics
Data Set yPih128–184
SeMetTah1
SRMEEVD
Pih1187–344
Spagh120–255
SRMEEVD
Spagh265–380
SRMEEVD
SeMet mPih11–200
ELDpSDDEF
mPih147–179
SELDpSDDEF
mPih147–179
SO4
a (A˚) 39.75 56.01 52.05 63.57 49.90 50.22 69.86
b (A˚) 48.29 78.38 59.12 96.51 61.67 67.73 50.14
c (A˚) 96.28 98.79 65.86 52.09 114.26 104.02 35.18
a, b, g (A˚) 90, 90, 90 90, 90, 90 63.42, 67.5,
82.43
90, 90, 90 90, 90, 90 90, 90, 90 90, 103.21, 90
Space group P21 C 2 2 21 P 1 P 21 21 21 P 21 21 21 P 21 21 21 C 1 2 1
Wavelength (A˚) 1.03666 1.5419 0.9200 0.9200 0.9795 0.92 1.54187
Resolution limit (A˚) 50–2.03
(2.08–2.03)
39.2–2.11
(2.16–2.11)
54.8–2.54
(2.61–2.54)
48.5–3.0
(3.08–3.0)
54.7–3.06
(3.14–3.06)
56.76–3.3
(3.48–3.3)
34.25–2.1
(2.16-2.1)
Number of observations 23,130 (1,520) 12,533 (623) 20,092 (1,479) 6,373 (469) 68,364 (6,356) 66,348 (5,693) 29,158 (6,845)
Completeness (%) 97.9 (87.6) 97.4 (67.3) 94.0 (94.1) 94.3 (94.6) 90.1 (56.4) 99.6 (99.8) 98.1 (96.4)
Multiplicity 3.0 (2.3) 56.6 (3.0) 2.7 (2.7) 3.3 (3.4) 10.8 (4.3) 11.7 (12.5) 4.3(4.1)
Rmerge (%) 0.071 (0.360) 0.048 (0.210) 0.096 (0.358) 0.080 (0.510) 0.12 (0.519) 0.168 (0.595) 0.076 (0.173)
Rpim(I) (%) 0.061 (0.0354) 0.006 (0.133) 0.082 (0.344) 0.058 (0.362) 0.042 (0.303) 0.056 (0.207) 0.046 (0.176)
Mean I/sI 9.7 (2.2) 83.7 (5.7) 8.1 (2.0) 12.5 (2.0) 15.4 (2.5) 12.8 (4.7) 22.7(14.9)
Refinement
Resolution Range (A˚) 50–2.03 39.2–2.11 54.8–2.6 48.5–3.0 54.7–3.06 56.76–3.3 34.25–2.1
Rcryst 0.1855 0.1688 0.2403 0.2414 0.224 0.2135 0.1278
Rfree 0.2367 0.2101 0.2671 0.2913 0.2814 0.3055 0.1826
No. protein atoms 2,770 1,624 3,923 1,786 2,043 1,778 1,024
No. ligand atoms 12 6 6 0 0 0 21
No. solvent atoms 249 89 80 12 0 15 178
Mean B-factor (A˚) 37.13 23.5 43.7 63.2 66.9 16.1 13.7
Rmsd bond lengths (A˚) 0.010 0.005 0.005 0.003 0.011 0.01 0.007
Rmsd bond angles () 1.04 0.913 0.751 0.671 1.84 1.3 1.02
Ramachandran statistics (%)
Favored 96.2 98.4 99.2 95 83.9 80.8 98.5
Allowed 3.8 1.6 0.8 5.0 12 17.9 0
Outlier 0 0 0 0 4.1 1.3 1.5
Highest resolution shell in parentheses.
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Structure of R2TP Core InteractionsZhang et al., 2005). To test this with Tah1, we co-immunoprecip-
itated a dimeric C-terminal construct of Hsp90 with FLAG-
tagged Tah1 in the absence or presence of a monomeric
TPR-domain cochaperone, Cpr6 (Figure 3B). The levels of
C-Hsp90 co-immunoprecipitated by FLAG-Tah1 were pro-
gressively decreased as the concentration of Cpr6 present
increased, consistent with Cpr6 titrating out the available
C-Hsp90. However no Cpr6 was co-immunoprecipitated at
any level, indicating that a FLAG-Tah1-(Hsp90)2-Cpr6 mixed
cochaperone complex was not formed. This is completely
consistent with Tah1 and Hsp90 interacting as a homogeneous
2:2 (Hsp902:Tah12) stoichiometric complex, as determined by
size exclusion chromatography (Figure 3A), in which both
MEEVD sites are occupied.
The absence of the mixed (Tah1 and Cpr6) Hsp90 complex
raises the question as to how Tah1 binding excludes simulta-
neous binding of other monomeric TPR domains. One possibility
is that Hsp90-bound Tah1 dimerizes and thus excludes other
monomeric TPR domains from binding. Previous work sug-808 Structure 22, 805–818, June 10, 2014 ª2014 The Authorsgested that Tah1 might be able to form dimers, although very
weakly, and the biological relevance of this remained undefined
(Millson et al., 2008). Using a lysine-specific crosslinker (see
Experimental Procedures), we were able to trap a Tah1 dimer
species in solution (Figure 3C), supporting the idea that Tah1
may dimerize, a process that would be greatly enhanced once
bound to Hsp90, and thus exclude other monomeric TPR
domain-containing proteins from forming a mixed TPR domain
complex.
Hsp90 Interaction with Spagh/RPAP3
In metazoa, the role of Tah1 is taken by Spagh/RPAP3—a much
larger protein with two TPR domains identifiable in its amino acid
sequence. We postulated that Spagh/RPAP3 might interact with
dimeric Hsp90 as a monomer by utilizing each of its tandem TPR
domains to bind to the MEEVD motifs on one Hsp90 dimer. To
test this, we analyzed the interaction of the tandem TPR region
of human Spagh/RPAP3120–395 (TPR2) with a C-terminal Hsp90
peptide, and with dimeric Hsp90, by ITC at 30C and 10C.
Figure 3. TPR Dimerization and Binding to the
Hsp90 Dimer
(A) SEC of cHsp90, Tah1-Pih1p187–344, and cHsp90-
Tah1-Pih1p187–344 complex. The elution volume of the
cHsp90-Tah1-Pih1p187–344 complex is consistent with a
cHsp902-Tah12-Pih1p2
187–344 stoichiometric complex .
(B) Exclusive homogenous occupation of both MEEVD
sites on the Hsp90 dimer by Tah1. Left-hand gel:
a-FLAG immunoprecipitation controls showing immu-
noprecipitation of FLAG-Tah1, but no interaction with
the TPR-domain Hsp90 cochaperone Cpr6 or the
dimeric C-terminal domain of Hsp90. A protein band
derived from the a-FLAG antibody system is indicated.
Right-hand gel: immunoprecipitation of FLAG-Tah1
coprecipitates Hsp90 C-domain, but the yield is
diminished in the presence of increasing concentrations
of Cpr6. No Cpr6 is precipitated by FLAG-Tah1 even at
very high Cpr6 concentrations, showing that mixed
loading of Cpr6 and Tah1 onto the Hsp90 C terminus
does not occur and that Tah1 exclusively occupies both
MEEVD sites simultaneously.
(C) SDS-PAGE gel showing migration of native Hsp90
and Tah1 proteins and after crosslinking with DMS (see
Experimental Procedures). Tah1 shows a substantial
yield of crosslinked dimer comparable in level to that
obtained for Hsp90, which is a known obligate dimer.
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Structure of R2TP Core InteractionsMutant data (see below) suggested a molar ratio indicating two
copies of the peptide binding to a single molecule of Spagh/
RPAP3-TPR2 and supporting the hypothesis that both Spagh/
RPAP3 TPR domains are competent for Hsp90 binding (Fig-
ure 4A). Using a two site fittingmodel, the C-terminal Hsp90 pep-
tide bound to Spagh/RPAP3-TPR2 with tight affinity at one site
(KD = 1.49 and 1.0 mM at 30
C and 10C, respectively) and
with moderate affinity at the other site (KD = 23.6 and 24.0 mM
at 30C and 10C, respectively). Consistent with these findings,
we found that Spagh/RPAP3-TPR2 bound to a Hsp90 dimer with
KD = 6.8 mM, but with a 1:2 molar ratio, suggesting that a single
molecule of Spagh/RPAP3 binds simultaneously to both C-ter-
minal MEEVD motifs of Hsp90 dimer (Figure 4B). The binding
of Spagh/RPAP3, and indeed Tah1 and Tah1-Pih1 complex
had no major effect on the ATPase activity of yeast Hsp90 and
human Hsp90b (Figure S2), consistent with a previous report
(Eckert et al., 2010).
We next determined the crystal structures of each of the TPR
domains (TPR1 and 2) of human Spagh/RPAP3 cocrystallized
with the Hsp90 C-terminal peptide. Spagh-TPR1125–250 consists
of seven a helices, the first five of which align with the five-helix
TPR domain of Tah1. Spagh-TPR2267–381 consists of six a heli-
ces, with the first five again aligning with Tah1-TPR (Figure 4C).
The N-terminal helix of Spagh-TPR2 is double the length of the
N-terminal helices of Tah1 or Spagh-TPR1 and projects out of
the core TPR domain (Figure 4C). In both Spagh/RPAP3 TPR
domains, the Hsp90 C-terminal peptide is bound in the groove
formed by the first five a helices. The peptide bound to TPR2
adopts a compacted conformation very similar to the Tah1 com-
plex, making extensive interactions with the walls of the groove.
The Hsp90 peptide bound to TPR1makes fewer interactions and
is less well structured, but in both cases the a-carboxyl and the
side chain of the C-terminal aspartic acid are bound by a
‘‘carboxylate clamp’’ (Scheufler et al., 2000), anchored by the
side chains of Asn 172 (TPR1) and Asn 321 (TPR2), each of which
make a bidentate interaction with the peptide NH and a-carboxyl
of the C-terminal aspartic acid residue of the Hsp90 peptide
(Figure 4D).
We tested the binding model suggested by the ITC experi-
ments by introducing mutations into either Spagh/RPAP3-TPR
domain that should disrupt binding of the Hsp90 C-terminal
MEEVD motif to that TPR domain only. Mutation of TPR1
(N172E) or TPR2 (N321E) and fitting with a two site model
suggested that binding for one site (nonmutant site) remained
unaffected (N172E-TPR1 mutant, TPR2: KD = 9.7 mM andFigure 4. Structure and Function of Spagh/RPAP3 TPR Domains
(A) ITC binding curve for human Hsp90 C-terminal peptide binding to Spagh/RPA
(right: KD1 = 1.0 mM and KD2 = 24 mM, two site fitting). KD estimates are consis
peptide binds in an2:1 (two Hsp90 peptides to one Spagh/RPAP3) molar ratio co
KD = 0.94 mM and TPR2, KD = 9.7 mM).
(B) ITC binding curve for Spagh/RPAP3265–380 binding to full-length Hsp90 dime
(C) Structural comparison of yeast Tah1 TPR-domain (left) and TPR1 (center) an
Spagh/RPAP3 TPR domains superimpose with the minimal Tah1-TPR domain. T
magenta.
(D) ‘‘Carboxyl’’ clamp interactions with the C terminus of the Hsp90 tail-peptide
peptide is anchored on the side chain of Asn 172 in TPR1 and Asn 321 in TPR2.
(E) Pull-down of Spagh/RPAP3120-395 tandem TPR segment by His6-Hsp90b. Wild
whereas a TPR2 mutant (N172E) diminishes interaction. Mutation of both TP
involvement of both TPRs in Hsp90 interaction.N321E-TPR2 mutant, TPR1: KD = 0.94 mM), whereas the
mutated TPR sites were compromised for binding (N172E-
TPR1 mutant, TPR1: KD = 231 mM and N321E-TPR2 mutant,
TPR2: KD = 109 mM; Figures S3A and S3B). The N172E-
N321E double mutant failed to show tight binding altogether
(Figure S3C), thus confirming that both TPR domains were
compromised by the mutations.
Next we used His-tagged Hsp90 in pull-down assays to test
whether they bound the TPR domainmutants (Figure 4E) and ob-
tained results that were consistent with those from the ITC ex-
periments. Taken together with the higher affinity and 1:2 molar
ratio observed for native Spagh/RPAP3-TPR2 binding to the
Hsp90 dimer (one Spagh/RAP3 molecule: one Hsp90 dimer),
these data indicate that the two TPR domains bind both C-termi-
nal MEEVD motifs of Hsp90 dimer simultaneously, with the
stronger binding TPR1 making the nucleating interaction that
facilitates binding of the weaker TPR2.
Structure of Pih1 N-Terminal Domain
Interaction with Tel2 involves the N-terminal segment of Pih1
(Horejsı´ et al., 2010), which contains a conserved region of
unknown structure (henceforth, PIH domain). We determined
the crystal structure of the mouse PIH domain1–200 (Figure 5A)
with single-wavelength anomalous dispersion phasing of Tel2-
peptide cocrystals (see below) grown with SeMet protein
(see Experimental Procedures) and used this to phase the
mPih47–179 apo and SELDpSDDEF peptide-bound structures,
which were refined to 2.1 and 3.3 A˚, respectively (Table 1). We
also obtained crystals of an essentially identical region of
budding yeast Pih128–184 and determined the structure of this
with molecular replacement (Figure 5A).
The PIH domain consists of a twisted five-stranded b sheet
with one face traversed by a helix-turn-helix segment connecting
strands 4 and 5, and the other face traversed by a coil segment
extending from the end of b strand 5. An additional a helix con-
necting strands 2 and 3 projects from the end of the sheet and
packs against the larger of the other two helices.
Pih1-Tel2 Interactions
A number of CK2 phosphorylation sites in a central and probably
unstructured segment of Tel2 (Takai et al., 2010) have been impli-
cated in mediating interaction with the R2TP complex (Horejsı´
et al., 2010). To define which of these are directly involved in the
interaction with Pih1, we performed a series of ITC experiments
using the mPIH domain and Tel2-derived phosphopeptides.P3 at 30C (left: KD1 = 1.49 mM and KD2 = 23.6 mM, two site fitting) and 10C
tent between the two temperatures indicating an accurate fit to the data. The
nsistent with Spagh/RPAP3mutant binding data (Figures S3A and S3B; TPR1,
r with an 1:2 molar ratio with KD = 6.8 mM.
d TPR2 domains (right) from Spagh/RPAP3. The N-terminal five helices of the
he Ca-trace of the bound Hsp90 C-terminal peptide in each case is shown in
by Spagh/RPAP3-TPR1 (left) and TPR2 (right). The C-terminal residue of the
-type Spagh/RPAP3 and a TPR1 mutant (N321E) are efficiently coprecipitated,
R domains effectively abolishes coprecipitation with Hsp90, confirming the
Structure 22, 805–818, June 10, 2014 ª2014 The Authors 811
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Structure of R2TP Core InteractionsConsistent with the requirement for CK2 phosphorylation, an
unphosphorylated peptide derived from mouse Tel2 residues
484–496 showed little affinity for the PIH domain (Figure 5B).
The same peptide phosphorylated on Ser 486 or Ser 488 alone
showed weak to modest binding (KD > 100 and 15.3 mM,
respectively; Figure S4A and SB). In contrast, a pSer 492 and a
bis-phosphorylated (pSer 488 and pSer 492) peptide showed
significantly higher affinity with KD = 0.39 and 0.17 mM, respec-
tively (Figure 5B). We also tested the bis-phosphorylated pSer
486 and pSer 488 peptide and found this bound only weakly to
the PIH domain (KD = 37.9 mM; Figure S4C). A Tel2 peptide in
which pSer492was replaced by a phosphothreonine bound sub-
stantially weaker than the native phosphoserine version (KD =
45.7 mM; Figure S4D) suggesting that at least in the context of
the Tel2 sequence, the PIH domain is specific for phosphoserine.
We next obtained crystals of a complex of the PIH domain and
the Ser 488-Ser 492-bis-phosphorylated Tel2 peptide. The
phosphopeptide binds to an intensely basic patch in the high-
resolution apo-structure (Figure 5C) formed by the loop connect-
ing b strands 3 and 4; the faces of b strands 1, 2, and 5; and the
coil segment C-terminal to b strand 5. Electron density is evident
for the Tel2 peptide from residue 488 to 496, but side chains are
only well defined for residues 489–495 (Figure 5D).
The Tel2 phosphopeptide binds as a 310 helix stabilized by a
backbone peptide hydrogen bond between Asp 491-C=O
and Asp 494-NH and reinforced by a hydrogen bond between
the side chain of Asp 491 and Asp 493-NH. The core of the
PIH domain interaction with the Tel2 phosphopeptide is pro-
vided by interlinked hydrogen bonds between the side chains
of Lys 57, Lys 64, and Lys 113 from Pih1, and the side chain
phosphate and carboxyl groups of pSer 492, Asp 491, and Asp
493 from Tel2. This is reinforced by hydrogen bonds from the
side chains of Asp 493 and Asp494 of Tel2 with the peptide
NHs of Lys 166 and Ala 112 of Pih1, respectively. An additional
hydrophobic interaction is provided by Tel2-Phe 496, which slots
into a small crevice formed by the side chains of Ala 112, Arg
168, and Leu 171 of Pih1 (Figure 6A). Tel2-pSer 488 is poorly
ordered in the complex and makes no visible interactions with
the PIH domain. This is consistent with the weak binding of a
Tel2 peptide phosphorylated on this residue alone, and the small
additional contribution it makes to the affinity provided by pSer
492, which dominates binding of this segment of Tel2 to the
PIH domain.
All the PIH residues involved in interactions with the mouse
Tel2 phosphopeptide are conserved in sequence and in the
three-dimensional structure in the yeast Pih1 protein, and align-
ment of mammalian and yeast Tel2 sequences identifies aFigure 5. Structure of PIH Domain
(A) Secondary structure cartoon of mPih1-PIH domain (left) and yeast Pih1p-PIH
(B) ITC binding curve for peptides from Tel2 spanning the cluster of putative C
unphosphorylated peptide (left) shows no binding, whereas phosphorylation of Te
submicromolar affinity with KD = 0.39 and 0.17 mM, respectively.
(C) Electrostatic surface (blue: +ve, red: ve) of mPIH domain cocrystal structur
intensely basic patch complementary to the multiple negative charges carried by
the bound peptide were visible. The side chain of pSer 486 was only partially vis
(D) The Tel2-phosphopeptide binds in a compact 310-helical conformation in a d
segment of the PIH domain. The PIH domain and the mode of binding of the pho
recognition domains. Only amino acid residues 486–496 of the bound peptide wsequence homologous to the CK2 site in metazoan Tel2
centered on a phosphorylation site at Ser 419 in yeast Tel2
(UniProt P53038). The segment carrying Ser 419 was excised
from the polypeptide used in the determination of the yeast
Tel2 structure (Takai et al., 2010).
The PIH domain itself and its mode of binding to the Tel2 phos-
phopeptide are distinct frompreviously reported phosphoserine/
phosphothreonine-binding domains such as BRCT or FHA do-
mains (Ali et al., 2009; Kilkenny et al., 2008; Qu et al., 2013). To
verify the binding site in the crystal structure biochemically, we
used ITC to measure the binding of the Ser 488-Ser 492-bis-
phosphorylated Tel2 peptide to the PIH domain with mutation
of residues implicated in phosphopeptide binding by the crystal
structure. Consistent with the crystal structure, no or very weak
bindingwas observedwith Lys>Glu charge reversal mutations
of Lys 57 or Lys 64 (Figure 6B, left and center). Mutation of the
highly conserved Lys 153 on the opposite face of the PIH domain
had no effect of Tel2 phosphopeptide binding (Figure 6B, right).
Role of Pih1 Interactions In Vivo
Previous studies revealed the importance of the CK2 sites in Tel2
in connecting the TTT complex to the R2TP/prefoldin and Hsp90
complexes (Horejsı´ et al., 2010). Consistent with the role of the
TTT complex in assembly/stabilization of PIKK proteins (Takai
et al., 2010), mutation of these sites resulted in destabilization
of Smg1 and mTOR in vivo.
With the detailed structural insights into Pih1 function
described here, we sought to confirm the importance of these in-
teractions by mutating Pih1. We constructed budding yeast
strains that were (1) lacking Pih1p, (2) expressing a Pih1p trun-
cated at residue 165 and therefore lacking the structurally
defined Hsp90-binding CS domain, (3) expressing Pih1p with
the biochemically characterized charge reversal mutations
that disrupt Tel2 phosphopeptide binding (see above), and
(4) Pih1p combining CS domain deletion and Tel2 phospho-
peptide-binding site mutations and determined their growth
characteristics. The Pih1p-deleted strain showed significant
temperature sensitivity relative to wild-type. This temperature
sensitivity could be complemented by expression of either the
CS-deleted or the Tel2p-binding disrupted Pih1p protein, but
not by the Pih1p impaired in interaction with both Hsp90 and
Tel2 (Figure 6C). Although the TTT complex has been implicated
in stabilization and activation of the DNA damage-sensing PI3K-
like kinases ATR and ATM in mammalian systems (Takai et al.,
2010), we found no sensitivity to a DNA-damaging agent in the
temperature sensitive pih1D yeast strain relative to wild-type
(Figure S5).domain (right), both rainbow colored. N: blue/ C: red.
K2 phosphorylation sites implicated in mediating interaction with Pih1. The
l2-Ser 492 (center), and bis-phosphorylation of Ser 488 and Ser 492 (right) gives
e with the bis-phosphorylated Tel2 phosphopeptide. The peptide binds to an
the acidic side chains of the phosphorylated peptide. Only residues 486–496 of
ible.
epression formed by the curved face of the central sheet and C-terminal coil
sphopeptide are quite distinct from previously characterized phosphorylation
ere visible. The side chain of pSer 486 was only partially visible.
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Figure 6. PIH Domain–Tel2 Phosphopeptide Interactions
(A) Interactions betweenmPIH domain and Tel2 phosphopeptide. The peptide is well ordered from Leu 490 to Phe 496. The core of the interactions is provided by
PIH domain residues Lys 57 and Lys 64, which form a network of charge interactions and hydrogen bonds with the carboxyl side chains of Tel2 residues Asp 491
and Asp 493, and the phosphatemoiety of pSer 492. Only residues 486–496 of the bound peptidewere visible. The side chain of pSer 486was only partially visible.
(B) Mutation of PIH domain residues Lys 57 (left) or Lys 64 (center) effectively abolishes Tel2-phosphopeptide binding as measured by ITC. Charge reversal of a
conserved residue Lys 153, which is not implicated in Tel2 binding by the crystal structure, has no effect on the affinity of the PIH domain for the phosphopeptide
(right).
(C) Growth of yeast with modified Pih1. Deletion of Pih1 shows a temperature-sensitive (ts) phenotype, whereas deletion of only the CS domain (Pih11–163), which
mediates recruitment to Hsp90, is not ts. Mutation of residues implicated in phospho-Tel2 binding (K58 equivalent to mouse K64, and K160 equivalent to mouse
K166) in isolation did not generate a ts phenotype; however, simultaneous disruption of Tel2 binding and Hsp90 recruitment elicits the ts growth phenotype.
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Figure 7. Assembly of the Hsp90-R2TP-TTT Supercomplex
(A) Structure of the overall yeast Hsp90-R2TP-TTT supercomplex required for
activation of PIKK enzymes such as TOR. The data presented here provide
detailed insights into the chain of protein-protein interactions connecting the
C terminus of Hsp90 to the TPR domain of Tah1, the C-terminal segment of
Tah1 to the CS-domain of Pih1, and the PIH-domain of Pih1 to the CK2 sites on
Tel2.Whether Rvb1/2 andHsp90 directly contact the client PIKK remains to be
determined. Tah1 binds Hsp90 as a dimer, occupying both TPR-binding sites
on an Hsp90 dimer. However, whether this causes recruitment of a second
Pih1-complex and potentially an additional TTT-PIKK complex is unknown.
(B) As in (A), but for the metazoan system where Tah1 function is replaced by
Spagh/RPAP3, which binds both TPR-binding sites on an Hsp90 dimer as a
single polypeptide. The role of the additional N- and C-terminal domains of
Spagh/RPAP3 in PIKK activation remains to be determined.
Structure
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The Hsp90 system is implicated in assembly, stabilization, and
activation of a plethora of proteins and complexes including pro-tein kinases (conventional and PIKK), steroid hormone recep-
tors, NLR innate immunity receptors, and both viral and cellular
DNA and RNA polymerases (Pearl et al., 2008). Recruitment of
this wide-ranging clientele to Hsp90 is mediated by cochaper-
ones, adaptors that interact simultaneously with Hsp90 and
the specific client protein class. Conventional protein kinases,
for example, are recruited by Cdc37 (Pearl, 2005), which arrests
the ATPase-coupled conformational cycle of Hsp90 (Siligardi
et al., 2002) and silences the kinase activity of the client (Polier
et al., 2013).
PIKKs are recruited by a far more complicated system
involving a chain of protein connections, mediated by an
Hsp90-binding TPR-domain protein (Tah1 or Spagh/RPAP3)
coupled to the CS-domain of Pih1. The PIH-domain of Pih1
then binds the Tel2 component of the TTT complex, which in
turn binds the client (Kakihara and Houry, 2012). Pih1 also binds
the AAA-ATPases Rvb1 and Rvb2 via a segment between the
PIH and CS domains (Paci et al., 2012; Figures 7A and 7B).
The mechanistic role of the Rvb1/Rvb2 complex, which is impli-
cated in numerous processes as well as PIKK stabilization/
activation, is unknown. However, it probably involves Pih1-medi-
ated interaction of Rvb1/Rvb2 with the PIKK client and may be
partly redundant with Hsp90 function because disruption of
both Tah1-binding (and hence Hsp90 association) by Pih1, and
phospho-specific interaction of Pih1 with Tel2, were required
to phenocopy Pih1 deletion in yeast cells.
The R2TP-TTT nexus is a more protracted and convoluted
link between client and chaperone than for the conventional
protein kinases, which form an intimate complex with Hsp90
and Cdc37 (Vaughan et al., 2006), and it is not clear whether,
and if so, how, Hsp90 and a PIKK client protein interact
directly. Nonetheless, as with conventional protein kinases,
the ATPase activity of the chaperone plays an important role
and its pharmacological inhibition impairs PIKK stability (Takai
et al., 2010).
Spagh/RPAP3 and Tah1 Interaction with Hsp90
The TPR1 and TPR2 domains of Spagh/RPAP3 have a typical
TPR domain structure, but lack the distinct hydrophobic pocket
formed between helices 5 and 7, into which the methionine side
chain of the MEEVD motif binds (Morgan et al., 2012; Zhang
et al., 2005). Instead and similar to Tah1, the methionine side
chain packs against the surface of helix 5 and remains partially
exposed. Whether this mode of binding, which is conserved be-
tween Tah1 and Spagh/RPAP3, has any special biological signif-
icance remains to be determined.
Although they fulfil the same role of bridging Pih1 to Hsp90,
Tah1 and Spagh/RPAP3 have significant structural and func-
tional differences. Our data show that two molecules of Tah1
can bind to an Hsp90 dimer and that each of these can recruit
a molecule of Pih1, generating a fully symmetric (Hsp90)2-
(Tah1)2-(Pih1)2 complex. In principle, this dimer symmetry may
be further propagated into complexes with TTT and other factors
that Pih1 mediates, but whether this actually occurs in vivo
remains to be determined. In contrast we find that only a single
molecule of Spagh/RPAP3 binds to an Hsp90 dimer, generating
an inherently asymmetric (Hsp90)2-(Spagh/RPAP3)1 complex
capable of recruiting a single Pih1 and downstream partners
(Figure 7).Structure 22, 805–818, June 10, 2014 ª2014 The Authors 815
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Our structural and mutational data characterize the PIH domain
as a phosphopeptide-binding domain that appears exquisitely
adapted to providing specific interactions with phosphoserines
(and possibly phosphothreonines) embedded in highly acidic
surrounding sequences, characteristic of CK2 phosphorylation
sites. The interaction of the PIH domain and the Tel2 phospho-
peptide is highly unusual when compared with other known
phosphopeptide binding domains. The phosphoserine phos-
phate group and the side chain carboxyls of the flanking
aspartic acid residues on the Tel2 peptide cooperate in an
interconnecting network of polar interactions with lysine resi-
dues 57 and 64 in the PIH domain. An additional interaction
with the PIH domain main chain is provided by the aspartic
acid side chain +2 relative to the phosphoserine. Whereas
our data show that the PIH domain has an absolute require-
ment for a phosphoserine for binding, the surrounding acidic
residues also make a substantial contribution, so that a Tel2-
pSer 486 peptide, which lacks the 1 and +2 aspartic acid
residues, only binds very weakly, while the Tel2-pSer 488
peptide, which has acidic residues at 1 and +1, binds with
15 mM affinity, but still 40-fold weaker than the Tel2-pSer
492 peptide with the full DpSDD core sequence. An additional
source of specificity may be contributed by the hydrophobic
interaction of Tel2-Phe 496, positioned +4 relative to the
phosphoserine. Tel2 sequences from a range of metazoa
conserve a large hydrophobic residue at this position, suggest-
ing a functional role.
Because Hsp90 and the R2TP complex are individually and
collaboratively implicated in a range of biological processes,
we speculated that the PIH domain of Pih1 might facilitate phos-
phorylation-dependent recruitment of other proteins in addition
to Tel2. To test this, we performed a bioinformatics search of
known phosphorylation sites curated in PhosphoSitePlus (Horn-
beck et al., 2004) using a search motif based on the high-affinity
Tel2-p492 sequence D[pSpT]DDx[FLIM]. Although replacement
of phosphoserine by phosphothreonine in the Tel2 motif dimin-
ished the affinity for Pih1 (Figure S4D), we considered the possi-
bility that this effect might be context specific, and sowe allowed
for either phosphorylated residue in the search motif. The search
yielded 46 putative binding sites in human proteins (Table S1),
although none in known components of R2TP-dependent sys-
tems such as snoRNPs or RNA polymerases. The identified pro-
teins function in a wide range of biological processes and
whether their matching phosphorylation sites mediate biologi-
cally significant interactions remains to be seen. Within these,
the search motif identifies a well-documented and conserved
phosphorylation site (554-MANDpSDDSIS-563) in the DNA
double-strand break recognition and resection protein, Mre11.
A phosphopeptide based on this sequence (MANDpSDDSI)
bound the Pih1-PIH domain with low micromolar affinity (KD =
6.4 mM; Figure S6) in ITC experiments, suggesting that the inter-
action could occur in vivo. ATM interaction and focus formation
by the MRN (Mre11-Rad50-Nbs1) complex is impaired in cells
treated with Hsp90 inhibitors, and the MRN complex and
Hsp90 coprecipitate (Dote et al., 2006), but the nature of the pre-
sumed cochaperone system that mediates Hsp90-MRN interac-
tion has not been determined. The presence of a functional PIH
domain-binding motif in Mre11 raises the intriguing possibility816 Structure 22, 805–818, June 10, 2014 ª2014 The Authorsthat Hsp90 recruitment is mediated by R2TP, but further work
will be required to test this.
A domain homologous to the PIH domain structurally charac-
terized here has been identified in kintoun/DNAAF2/PF13, a fac-
tor required for cytoplasmic assembly of dynein arm complexes
prior to their transport into cilia (Omran et al., 2008; Yamamoto
et al., 2010). Residues in themPIH domain involved in interacting
with the phosphorylated Tel2 CK2 site are conserved in kintoun/
DNAAF2/PF13, suggesting that it also mediates phosphoryla-
tion-dependent protein-protein interactions, although the target
of this is currently unknown. A CS domain homologous to that in
the C-terminal region of Pih1 is also detectable in kintoun/
DNAAF2/PF13 immediately C-terminal of the PIH domain,
with a second CS domain identifiable downstream. Kintoun/
DNAAF2/PF13 has recently been shown to interact with
DYX1C1 (Tarkar et al., 2013), a TPR-domain and CS-domain
protein also implicated in axonemal dynein assembly and
mutated in human primary ciliary dyskinesia. The DYX1C1 TPR
domain conserves the pattern of residues involved in binding
the Hsp90 and/or Hsp70 C-terminal EEVD motif (see above),
and these chaperones are enriched in DYX1C1 cellular copreci-
pitates. While the details of these interactions are yet to be fully
described, it is likely that the chain of TPR, CS, and PIH domains
that mediate Hsp90 involvement with PIKKs via the R2TP system
structurally characterized here also play a key role in connecting
Hsp90 to the dynein assembly.
EXPERIMENTAL PROCEDURES
Protein Purification
pTwo-E expressed His-mPih11–200, mutants and mPIH147–179, were purified
by Talon affinity, gel filtration, and ion-exchange chromatography. mPih1
constructs were purified by Talon affinity and gel filtration chromatography.
Tah1p and the Tah1p-Pih1p187–344 complex was expressed in Escherichia
coli Rosetta (DE3) pLysS cells. Tah1p and the Tah1p-Pih1p187–344 complex
were purified by Talon affinity and gel filtration chromatography. Spagh/
RPAP3120–395 was expressed as a GST PreScission fusion and purified by
GST affinity and gel filtration chromatography. For selenomethionine (SeMet)
protein labeling, cells were grown in media containing SeMet.
Crystallography
Crystallizations were conducted at 10 mg/ml. The Tah1p-Pih1p187–344-
SRMEEVD complex was crystallized in 25% PEG 1500 (w/v) and a 100 mM
MIB buffer pH 6.0 (a mixture of malonic acid, imidazole, and boric acid) at
4C. Crystals for TPR1 of RPAP3 were obtained in 100 mM HEPES, pH 7.0,
and 20% PEG 8000 (w/v) at 4C, whereas those for TPR2 in were obtained
in 0.1 M Na-citrate pH 5.6, 20% PEG 4000 (w/v), and 20% 2-propanol at
4C. Crystals of TPR1 and TPR2 were obtained following proteolysis of
Spagh/RPAP3200–395 during crystallization. SeMet-mPih11–200 -Tel2 phospho-
peptide (QGSDpSELDpSDDEF) was crystallized at 14C in 0.1 M PCTP buffer
pH 8.0, 25% PEG 1500 (w/v). In contrast, mPih147–179-Tel2 phosphopeptide
was crystallized at 14C in 0.15 M NaKHPO4, 20% PEG 3350, and 0.1 M
Bis-Tris pH 6.5. Apo mPih147–179 crystallized in 0.02 M MgCl2.6H20, 0.002M
CoCl2, 0.05M HEPES pH 7.5, 2M (NH4)2SO4, and 0.001 M Spermine.
Crystals were harvested with glycerol (mPih1 constructs) or ethylene glycol
(all other constructs) and flash-frozen. Diffraction data were collected at 100 K
either on a Rigaku 007HF generator (l = 1.5419 A˚) or at Diamond Light Source
UK. Data were processed with CCP4 (Krissinel et al., 2004) and Phenix (Afo-
nine et al., 2012), and manual rebuilding was performed in Coot (Emsley and
Cowtan, 2004). The Spagh/RPAP3-TPR1- and TPR2-peptide complexes
were solved by molecular replacement with the Tah1p structure. Data for
apo mPih147–179, mPih147–179-Tel2, and SeMet-mPih11–200-Tel2 complexes
were integrated, and scaled with XDS (Kabsch, 2010), and graphics were
depicted with PyMol (Schro¨dinger).
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Heat of interaction was measured on an ITC200 microcalorimeter (Microcal)
under the same buffer conditions (20 mM Tris, pH 7.5, containing 5 mM
NaCl). Aliquots of the Tel2 peptides at 350 mM were injected into 30 mM of
Pih1 at 30C. Interactions with Tah1 or Spagh/RPAP3120–395 were performed
in 10 mM Tris pH 7.5 and 5 mM NaCl at 10C and 30C. Aliquots of 600 mM
Tah1 were injected into 40 mM of yeast Hsp90, 400 mM of SRMEEVD injected
into 30 mM Tah1, 301 mM yeast Hsp90 injected into 25 mM yeast Tah1-Pih1
complex, and 400 mM SRMEEVD injected into 30 mM yeast Tah1-Pih1 com-
plex. For Spagh/RPAP3120–395 experiments, aliquots of 500 mM yeast Hsp90
were injected into 20 mM Spagh/RPAP3120–395 or 2 mM DDTSRMEEVD into
80 mM Spagh/RPAP3120–395 or mutants (N172E, N321E, and N172E-N321E).
Heats of dilution were determined by diluting injectant into buffer. Data were
fitted using a curve-fitting algorithm (Microcal Origin). ATPase assays were
previously described (Prodromou et al., 1999).
Cross-Linking and Pull-Downs
Increasing concentrations of Cpr6 and 70 mM Flag-Tah1p, Hsp90600–709 were
incubated in 20mMHEPES, pH 7.5, 150mMNaCl, 10% glycerol, 0.5% Igepal,
and 2 mM EDTA. Subsequently, 30 ml Anti-Flag M2 magnetic beads (Sigma-
Aldrich) were added. Beads were then washed, and the elute was depicted
with SDS-PAGE. Cross-linking experiments were previously described (Pro-
dromou et al., 2000).
Yeast Strains and Plasmids
The pih1 deletion strain (pih1::KanR in BY4741) was obtained from Euroscarf.
The Pih1 promoter and the full coding sequence were amplified cloned into the
NotI site of pRS415 (Stratagene). Truncated Pih1was constructed by inserting
a stop codon at Leu 168 and cloned into the NotI site of pRS415. The K58E or
K106E mutations were introduced into either the full-length or truncated Pih1
construct by site-directed mutagenesis.
Survival and Growth Assays
Yeast transformed with Pih1 expression constructs were grown in synthetic
complete media lacking leucine (SC-His). To determine temperature sensi-
tivity, 5-fold dilutions of logarithmically growing cultures were spotted onto
plates and incubated at the permissive (30C) or nonpermissive temperature
(37C) and imaged after 3 days. For growth rate analysis, yeast strains grown
to saturation in SC-His were diluted into fresh media and the optical density at
600 nm was measured. Data are represented as the average of three indepen-
dent experiments ± 1 SD.
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